ROBERT J FLANAGAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT J FLANAGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT J FLANAGAN. ROBERT J FLANAGAN is Director in MARTEK BIOSCIENCES CORP ($MATK) and Director in W. P. Carey Inc. ($WPC) and in Sagent Pharmaceuticals, Inc. ($SGNT) and Director in Sagent Pharmaceuticals, Inc. ($SGNT).
Latest Insider Trading Transactions of ROBERT J FLANAGAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MATK, SGNT, WPC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2020 | WPC | W. P. Carey Inc. | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 2,180 | 0 | 6,897 | 4.7 K to 6.9 K (+46.22 %) |
| Mar 05 2020 | WPC | W. P. Carey Inc. | FLANAGAN ROBERT J | Director | Buy | P | 82.29 | 1,000 | 82,290 | 4,717 | 3.7 K to 4.7 K (+26.90 %) |
| Jul 03 2018 | WPC | W. P. Carey Inc. | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 1,523 | 0 | 1,850 | 327 to 1.9 K (+465.75 %) |
| Apr 03 2018 | WPC | W. P. Carey Inc. | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 327 | 0 | 327 | 0 to 327 |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 11.60 | 5,103 | 59,195 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 433,770 | 9,434,498 | 0 | 433.8 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 2,000 | 43,500 | 0 | 2 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 8,050 | 175,088 | 0 | 8.1 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Gift | G | 0.00 | 4,150 | 0 | 8,050 | 12.2 K to 8.1 K (-34.02 %) |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 230 | 0 | 691 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 460 | 0 | 1,381 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 230 | 0 | 12,200 | 12 K to 12.2 K (+1.92 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 460 | 0 | 11,970 | 11.5 K to 12 K (+4.00 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 567 | 0 | 0 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 760 | 0 | 760 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 567 | 0 | 11,510 | 10.9 K to 11.5 K (+5.18 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 760 | 0 | 10,943 | 10.2 K to 10.9 K (+7.46 %) | |
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 930 | 0 | 1,860 | ||
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 930 | 0 | 10,183 | 9.3 K to 10.2 K (+10.05 %) | |
| Apr 13 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 921 | 0 | 921 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 567 | 0 | 9,253 | 8.7 K to 9.3 K (+6.53 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 760 | 0 | 8,686 | 7.9 K to 8.7 K (+9.59 %) |
| Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 27.87 | 15,000 | 418,050 | 0 | |
| Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 24.85 | 10,000 | 248,500 | 0 | |
| Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 11.84 | 323 | 3,824 | 0 | |
| Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
| Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
| Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
| Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | U | 31.50 | 10,000 | 315,000 | 0 | 10 K to 0 (-100.00 %) |
| Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | U | 31.50 | 332,609 | 10,477,184 | 0 | 332.6 K to 0 (-100.00 %) |
| Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | U | 31.50 | 8,675 | 273,263 | 0 | 8.7 K to 0 (-100.00 %) |
| Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 3,515 | 0 | 0 | |
| Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 2,533 | |
| Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 3,515 | 0 | 8,675 | 5.2 K to 8.7 K (+68.12 %) |
| Mar 23 2009 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 3,515 | 0 | 3,515 | |
| Mar 16 2009 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 2,034 | 0 | 0 | |
| Mar 16 2009 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 2,034 | 0 | 5,160 | 3.1 K to 5.2 K (+65.07 %) |
| Mar 17 2008 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 2,034 | 0 | 2,034 | |
| Mar 17 2008 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 2,907 | 0 | 0 | |
| Mar 17 2008 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 2,907 | 0 | 3,126 | 219 to 3.1 K (+1,327.40 %) |
| Dec 21 2007 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 25,341 | 0 | 332,609 | 307.3 K to 332.6 K (+8.25 %) |
| Dec 21 2007 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 105 | 0 | 219 | 114 to 219 (+92.11 %) |
| Mar 19 2007 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 2,907 | 0 | 2,907 | |
| Sep 12 2006 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | P | 21.48 | 2,500 | 53,700 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Sep 11 2006 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | P | 20.84 | 2,500 | 52,100 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Mar 20 2006 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 33.36 | 5,000 | 166,800 | 5,000 | |
| Mar 21 2005 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 55.85 | 10,000 | 558,500 | 10,000 | |
| Dec 23 2004 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | P | 49.62 | 2,000 | 99,240 | 2,000 | 0 to 2 K |
| Dec 23 2004 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Buy | P | 49.62 | 2,000 | 99,240 | 2,000 | 0 to 2 K |
| Mar 22 2004 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 60.15 | 15,000 | 902,250 | 15,000 |
Page: 1